Review/Advances in Neurological Therapeutics (2018). Immune–mediated central nervous system disorders

Abstract

Recent advances and new findings relating to multiple sclerosis (MS) and other inflammatory disorders in the central nervous system were reviewed. We adopted the studies regarding serum neurofilament light chain as an efficient biomarker for axonal damage in patients with MS, B cell targeted therapies for MS, the MRI technique that distinguishes MS from neuromyelitis optica spectrum disorder (NMOSD), plasma exchange as an acute–phase treatment for NMOSD, and cumulative information about myelin oligodendrocyte glycoprotein immunoglobulin G–positive disorder.